Clinical trial

(Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant…

NCT00075842 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00075842
Title (Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
Official title The Use Of Valeriana Officinalis (Valerian) In Improving Sleep In Patients Who Are Undergoing Adjuvant Treatment For Cancer" A Phase III Randomized, Placebo-Controlled, Double-Blind Study
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Fatigue, Sleep Disorders, Unspecified Adult Solid Tumor, Protocol Specific
Intervention type Dietary Supplement, Other
Interventions Valeriana officinalis extract, placebo
Enrollment 227
Start date Aug 1, 2003
Primary completion Mar 1, 2007
Completion Jan 1, 2010
First posted Jan 13, 2004
Last update posted Dec 6, 2016
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies